0001161697-22-000399.txt : 20220819 0001161697-22-000399.hdr.sgml : 20220819 20220819170254 ACCESSION NUMBER: 0001161697-22-000399 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220818 FILED AS OF DATE: 20220819 DATE AS OF CHANGE: 20220819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCENANY PATRICK J CENTRAL INDEX KEY: 0000929985 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 221181503 MAIL ADDRESS: STREET 1: C/O THERMOGENESIS CORP STREET 2: 2711 CITRUS ROAD CITY: RANCHO CORDOVA STATE: CA ZIP: 95742 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 08-18-2022 X0306 4 2022-08-18 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0000929985 MCENANY PATRICK J 355 ALHAMBRA CIRCLE, SUITE 801 CORAL GABLES FL 33134 1 1 0 0 President and CEO Common stock, par value $0.001 per share 2022-08-18 4 M 0 25000 2.53 A 4955217 D Common stock, par value $0.001 per share 2022-08-18 4 S 0 25000 13.934 D 4930217 D Common stock, par value $0.001 per share 2022-08-18 4 M 0 50000 2.53 A 4980217 D Common stock, par value $0.001 per share 2022-08-18 4 S 0 50000 13.930 D 4930217 D Common Stock, par value $0.001 per share 2022-08-18 4 M 0 50000 2.53 A 4980217 D Common stock, par value $0.001 per share 2022-08-18 4 S 0 50000 13.959 D 4930217 D Common stock,. par value $0.001 per share 2022-08-18 4 M 0 50000 2.53 A 4980217 D Common stock, par value $0.001 per share 2022-08-18 4 S 0 50000 13.951 D 4930217 D Common stock, par value $0.001 per share 2022-08-19 4 M 0 125000 2.53 A 5055217 D Common stock, par value $0.001 per share 2022-08-19 4 S 0 125000 14.0994 D 4930217 D Options to purchase common stock 2.53 2022-08-18 4 M 0 25000 0 D 2022-12-30 Common Stock 25000 3640834 D Options to purchase common stock 2.53 2022-08-18 4 M 0 50000 0 D 2022-12-30 Common Stock 50000 3590834 D Options to purchase common stock 2.53 2022-08-18 4 M 0 50000 0 D 2022-12-30 Common Stock 50000 3540834 D Options to purchase common stock 2.53 2022-08-18 4 M 0 50000 0 D 2022-12-30 Common Stock 50000 3490834 D Options to purchase common stock 2.53 2022-08-19 4 M 0 125000 0 D 2022-12-30 Common Stock 125000 3365834 D Shares were sold in various lots from $13.93 to $13.97 per share. The listed sales price represents a weighted average price for the shares sold. Shares were sold in various lots from $13.93 to $13.94 per share. The listed sales price represents a weighted average price for the shares sold. Shares were sold in various lots from $13.95 to $14.00 per share. The listed sales price represents a weighted average price for the shares sold. Shares were sold in various lots from $13.95 to $13.98 per share. The listed sales price represents a weighted average price for the shares sold. Shares were sold in various lots from $14.05 to $14.14 per share. The listed sales price represents a weighted average price for the shares sold. Shares were sold to cover the exercise price of options, tax withholding requirements (if applicable) and for personal reasons. The shares were not sold as a result of any agreement with the Company and Mr. McEnany remains an officer of the company. Options vested in three separate tranches beginning on December 30, 2016. /s/ Patrick J. McEnany 2022-08-19